Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barr (A.G.) PLC Director's Dealing 2021

Jul 6, 2021

5133_dirs_2021-07-06_b286d13b-d541-4f48-b821-9e1767b8eb64.html

Director's Dealing

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 3531E

Barr(A.G.) PLC

06 July 2021

GENERAL TEXT AMENDMENT

The following amendment has been made to the 'Director/PDMR shareholding announcement released on 6 July 2021 at 12:11 under RNS No 3359E.

Name change

All other details remain unchanged.

The full amended text is shown below.

6 July 2021

ANNEX

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Allen

2

Reason for the notification

a)

Position/status

Non-Executive Director at  A.G. BARR p.l.c.

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

A.G. BARR p.l.c.

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 4⅙p each

GB00B6XZKY75

b)

Nature of the transaction

Purchase of 10,000 A.G. BARR p.l.c. ordinary shares of 4⅙p by Mark Allen

c)

Price(s) and volume(s)

Mark Allen
Price(s) Volume(s)
£5.171128 10,000

d)

Aggregated volume

Aggregated price

10,000 shares

£51,711.28

e)

Date of the transaction

6 July 2021

f)

Place of the transaction

London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHDKABBQBKDFOK